The US-based com­pany Experic sup­ports clin­ical trials for phar­ma­ceu­tical com­pa­nies, for instance with man­u­fac­turing, filling, and labelling ser­vices as well as global logis­tics man­age­ment. The latest addi­tion to their tech­nology port­folio includes the assembly of med­ical and phar­ma­ceu­tical devices.

Since May 2020, an Assembly Lab ­expands the Harro Höfliger tech­nology port­folio at Experic. The semi-auto­matic assembly machine can be flex­ibly cus­tomized for var­ious devices, including autoin­jec­tors, pens and patch injec­tors. In addi­tion, the batch size can be deter­mined indi­vid­u­ally – a clear advan­tage in early phase clin­ical studies, where small batches are required.

State-of-the-art dosing equip­ment from Allmers­bach im Tal has been in place for cap­sule filling and micro­dosing since the Experic facility was com­mis­sioned in July 2019. For Harro Höfliger, the coop­er­a­tion with Experic builds upon its promise to sup­port cus­tomers from the product idea to market launch and well beyond.

Down­load this article as PDF file

Photos: Helmar Lünig, Experic